These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25895719)

  • 1. Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration.
    Harde H; Siddhapura K; Agrawal AK; Jain S
    Int J Pharm; 2015 Jun; 487(1-2):292-304. PubMed ID: 25895719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetanus toxoids loaded glucomannosylated chitosan based nanohoming vaccine adjuvant with improved oral stability and immunostimulatory response.
    Harde H; Agrawal AK; Jain S
    Pharm Res; 2015 Jan; 32(1):122-34. PubMed ID: 25030184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration.
    Jain S; Harde H; Indulkar A; Agrawal AK
    Nanomedicine; 2014 Feb; 10(2):431-40. PubMed ID: 24036099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetanus toxoid-loaded layer-by-layer nanoassemblies for efficient systemic, mucosal, and cellular immunostimulatory response following oral administration.
    Harde H; Agrawal AK; Jain S
    Drug Deliv Transl Res; 2015 Oct; 5(5):498-510. PubMed ID: 26195222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
    Pirouzmand H; Khameneh B; Tafaghodi M
    Pharm Biol; 2017 Dec; 55(1):212-217. PubMed ID: 27927058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administration.
    Harde H; Siddhapura K; Agrawal AK; Jain S
    Nanomedicine (Lond); 2015; 10(7):1077-91. PubMed ID: 25929566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
    Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
    Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment.
    Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
    J Pharm Sci; 2014 Nov; 103(11):3448-3456. PubMed ID: 25219511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostimulatory effect of tetanus toxoid loaded chitosan nanoparticles following microneedles assisted immunization.
    Siddhapura K; Harde H; Jain S
    Nanomedicine; 2016 Jan; 12(1):213-22. PubMed ID: 26554391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of humoral and cellular immunity in response to Tetanus and Diphtheria toxoids by supercritical carbon dioxide extracts of Hippophae rhamnoides L. leaves.
    Jayashankar B; Singh D; Tanwar H; Mishra KP; Murthy S; Chanda S; Mishra J; Tulswani R; Misra K; Singh SB; Ganju L
    Int Immunopharmacol; 2017 Mar; 44():123-136. PubMed ID: 28092864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of chitosan microspheres for tetanus, diphtheria and divalent vaccines: a comparative study of subcutaneous and intranasal administration in mice.
    Hashem FM; Fahmy SA; El-Sayed AM; Al-Sawahli MM
    Pharm Dev Technol; 2013; 18(5):1175-85. PubMed ID: 21985525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D; Staats HF; Gonçalves T; Borges O
    Eur J Pharm Biopharm; 2015 Jun; 93():149-64. PubMed ID: 25818119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes.
    Shukla A; Singh B; Katare OP
    Br J Pharmacol; 2011 Sep; 164(2b):820-7. PubMed ID: 21506959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of microencapsulated DwPT trivalent vaccine using water soluble chitosan and its in-vitro and in-vivo immunological properties.
    Walke S; Srivastava G; Routaray CB; Dhavale D; Pai K; Doshi J; Kumar R; Doshi P
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2044-2056. PubMed ID: 29037872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
    J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.
    Westerink MA; Smithson SL; Srivastava N; Blonder J; Coeshott C; Rosenthal GJ
    Vaccine; 2001 Dec; 20(5-6):711-23. PubMed ID: 11738734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
    Singh J; Pandit S; Bramwell VW; Alpar HO
    Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies.
    Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
    Int J Pharm; 2013 Jan; 441(1-2):636-42. PubMed ID: 23117021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.